5 results match your criteria: "Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute.[Affiliation]"
Background: No single marker of bladder cancer (BC) exists in urine samples with sufficient accuracy for disease diagnosis and treatment monitoring. The multiplex Oncuria BC assay noninvasively quantifies the concentration of 10 protein analytes in voided urine samples to quickly generate a unique molecular profile with proven BC diagnostic and treatment-tracking utility. Test adoption by diagnostic and research laboratories mandates reliably reproducible assay performance across a variety of instrumentation platforms used in different laboratories.
View Article and Find Full Text PDFProspective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
BMC Med
October 2023
Molecular Epidemiology Research Group, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany.
Article Synopsis
- FABP-4 is a lipid-binding protein linked to obesity that may influence tumor growth and insulin resistance, potentially impacting colorectal cancer (CRC) development.
- A study using pre-diagnostic plasma levels of FABP-4 involved 1,324 CRC cases compared with matched controls, and also used a Mendelian randomization approach with genetic data from over 58,000 CRC cases.
- Results showed no significant overall association between FABP-4 levels and CRC risk; however, a noteworthy correlation was found in women using the cis-MR approach, suggesting a possible link specifically in that demographic.
Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study.
J Cancer Surviv
June 2024
Cancer Control and Population Sciences Research Program, Huntsman Cancer Institute, Salt Lake City, UT, USA.
Purpose: Employment and financial hardships are common issues for working-age colorectal cancer patients. We surveyed colorectal cancer survivors to investigate employment, insurance, and financial outcomes by age at diagnosis.
Methods: Cross-sectional survey of six ColoCare Study sites regarding employment, insurance, and financial hardship outcomes.
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.
J Med Genet
July 2022
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Background: Epithelial tubo-ovarian cancer (EOC) has high mortality partly due to late diagnosis. Prevention is available but may be associated with adverse effects. A multifactorial risk model based on known genetic and epidemiological risk factors (RFs) for EOC can help identify women at higher risk who could benefit from targeted screening and prevention.
View Article and Find Full Text PDFPurpose There is limited information on how the COVID-19 pandemic has changed health behaviors among cancer patients. We examined the impact of the pandemic on changes in exercise behaviors and identified characteristics associated with these changes among cancer patients. Methods Cancer patients (n 1,361) completed a survey from August-September 2020 to assess COVID-19 pandemic-related changes in health behaviors and psychosocial factors.
View Article and Find Full Text PDF